S troke remains to be the leading cause of mortality in China and was responsible for ≈1.9 million deaths in 2013. 1 Despite advances in diagnosis and treatments for stroke, adherence to evidence-based stroke care has been suboptimal based on several national studies conducted before 2009. 2, 3 Since then, improving the quality of stroke care has become Background and Purpose-Stroke is a leading cause of death in China. Yet the adherence to guideline-recommended ischemic stroke performance metrics in the past decade has been previously shown to be suboptimal. Since then, several nationwide stroke quality management initiatives have been conducted in China. We sought to determine whether adherence had improved since then. However, there were no significant improvements in the rates of intravenous thrombolytic therapy and anticoagulation for atrial fibrillation. After multivariate analysis, there remained a significant 1.17-fold (95% confidence interval, 1.14-1.21) increase in the odds of delivering evidence-based performance metrics in the more recent time periods versus older data. The performance metrics with the most significantly increased odds included stroke education, dysphagia screening, smoking cessation, and antithrombotics at discharge. Conclusions-Adherence to stroke performance metrics has increased over time, but significant opportunities remain for further improvement. Continuous stroke quality improvement program should be developed as a national priority in China.
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November 2016 a national priority. 4 This interest has led to several quality management initiatives by the China Ministry of Health after 2008 to promote adherence to guideline-recommended performance measures for acute ischemic stroke. [4] [5] [6] [7] [8] We sought to assess the change in the quality of acute ischemic stroke care by comparing the adherence to guideline-recommended performance measures before 2009 with that after the implementation of these initiatives since 2009.
Methods

China National Stroke Registries
The China National Stroke Registry (CNSR) is a national hospitalbased, prospective stroke registry. 9 Data collected among 131 hospitals during September 2007 to August 2008 were used as CNSR phase 1 or the baseline for the current study. CNSR phase 2 was launched during June 2012 to January 2013 and consisted of 219 hospitals. Among them, 72 hospitals participated in both CNSR phase 1 and 2, 59 sites only in CNSR phase 1 and 147 hospitals only in phase 2. These 147 hospitals were selected by a Steering Committee using a convenient sampling method from the China National Network of Stroke Research developed by the National Center of Quality Management in Stroke Care including 491 hospitals and matched based on the comparability of the data from the 2007 to 2008 data, including geographic region, teaching status, hospital beds, and annual stroke discharges. The flow chart of the study is shown in Figure 1 . The study was approved by the Institutional Review Board of the Beijing Tiantan Hospital.
Case Identification and Data Abstraction
Trained research co-ordinators at each site examined all medical records of stroke patients to identify eligible cases for the registries. Adult inpatients (≥18 years of age) with acute ischemic stroke at admission as evidenced by brain computed tomography or magnetic resonance imaging were included. Informed consent was obtained from patients or legal representatives. All subjects received an evaluation using the National Institutes of Health Stroke Scale within 24 hours of hospital admission. The following variables are extracted from medical documents: patient demographics, onset-to-door time, health insurance schemes 10 (urban basic medical insurance schemes for urban and governmental employees and urban residents, new rural cooperative medical schemes for rural residents, commercial insurance, and self-payment), vascular risk factors, and implementation of performance measures for acute stroke care, final diagnosis, length of stay, modified Rankin scale at discharge, and in-hospital death. Hospital-level information included geographic region (eastern, central, and western areas according to the annual report on health statistics of China 11 ), teaching status, hospital bed size, and annual stroke volume. The definitions of the variables were described in the Table I in the online-only Data Supplement.
Quality Measures for Stroke Care and Prevention
A total of 13 guideline-recommended performance metrics were prespecified for this study by the Steering Committee based on the national standards, guidelines' recommendations, [6] [7] [8] and Get With The Guidelines-Stroke (GWTG-Stroke), 12 including 6 acute performance measures: (1) intravenous tissue-type plasminogen activator (tPA) in patients who arrive within 2 hours after symptom onset and treated within 3 hours, (2) antithrombotic medication within 48 hours of admission, (3) deep vein thrombosis prophylaxis within 48 hours of admission for nonambulatory patients, (4) dysphagia screening before any oral intake, (5) carotid imaging, (6) assessment or receiving of rehabilitation and 7 performance measures at discharge: (1) antithrombotic medication, (2) anticoagulation for atrial fibrillation, (3) antihypertensive medication for patients with hypertension, (4) medications for lowering low-density lipoprotein ≥100 mg/dL, (5) hypoglycemia medication for diabetes mellitus, (6) smoking cessation, and (7) stroke education (Table Ⅱ in the online-only Data Supplement).
A composite score was developed and defined as the total number of interventions actually performed among eligible patients divided by the total number of recommended interventions among eligible patients.
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Statistical Analyses
Both patient and hospital characteristics were reported as median with interquartile ranges for continuous variable and as frequency and percentage for categorical variables by 2 study period, CNSR phase 1 (2007-2008) and phase 2 (2012-2013 ). The differences are tested by χ 2 tests for categorical variables and Wilcoxon rank-sum test for continuous variables.
The primary outcomes were the difference in adherence to the guideline-based performance measures between the 2 study periods, as reflected, respectively, by 13 individual measures, the composite score, and the odds of fulfilling care opportunities for eligible performance measures as described in previous research. 13 As for the odds of fulfilling care opportunities, each measure for which a patient was eligible contributed an observation in the analysis, and the outcome was a dichotomized (1: measure met versus 0: measure not met). 13 For example, if a particular patient was eligible for 6 of the 8 performance measures and only received 3 of them, this patient contributed 6 observations to the analysis. Multiple regression models were developed to evaluate the difference in adherence to performance measure between the 2 study periods. These analyses adjusted for patient and hospital characteristics, including age, race, sex, insurance schemes, previous stroke/transient ischemic attack, diabetes mellitus, hypertension, dyslipidemia, coronary heart disease/previous myocardial infarction, atrial fibrillation, ever smoking, stroke severity, hospital geographic region, teaching status, number of hospital beds, and annual stroke discharges. Generalized estimating equations were used to account for within-hospital clustering. 
Downloaded from
The primary analysis included all hospitals in the CNSR phase 1 and 2. A sensitivity analysis was performed in 72 hospitals participated in both CNSR phase 1 and 2.
All tests are 2-tailed with P<0.05 regarded as the level of statistical significance. All statistical analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC). 
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are shown in Figure 2 and Sensitivity analysis of 72 hospitals participating in both phase 1 and 2 also revealed substantial improvements in the composite measure. Nine of the 13 individual performance measures (except for intravenous thrombolysis, early antithrombotics, deep vein thrombosis prophylaxis, and anticoagulation for atrial fibrillation) were improved ( Table 2) . Multivariate generalized estimated equations analysis revealed a 1.21-fold increase in the odds of receiving each performance measure from 2007 to 2012 (Table Ⅴ in the online-only Data Supplement).
Discussion
In the current study, we observed a marked improvement in overall adherence to guideline-recommended performance measures after implementing several quality management initiatives nationwide in China. Significant improvements were observed in the composite score and 9 out of 13 individual performance measures in the overall hospitals and in 72 hospitals participating in both CNSR phase 1 and 2. The improvement of individual performance measures and the composite score during the 5 years between 2 time periods was apparent even after adjusting for those previous reported patient' and hospital' variables affecting the care quality, such as age, sex, stroke severity, teaching status, and bed capacity. 13, 14 Potential factors for this improvement of the quality of care between 2007 to 2008 and 2012 to 2013 were inferred. First, during these 5 years, improving the quality of stroke care became a national priority, and several quality management initiatives of stroke care were implemented CI indicates confidence interval; CNSR, Chinese National Stroke Registry; DVT, deep vein thrombosis; GEE, generalized estimated equations; IV, intravenous; LDL, low-density lipoprotein; OR, odds ratio; and r-tPA, recombinant tissue-type plasminogen activator.
*Adjusted for patient characteristics of age, race, sex, insurance schemes, previous stroke/transient ischemic attack, diabetes mellitus, hypertension, dyslipidemia, coronary heart disease/previous myocardial infarction, atrial fibrillation, ever smoking, and stroke severity, and hospital characteristics of times of participating in the registries, geographic region, teaching status, number of hospital beds, and annual stroke discharges.
†N1 indicates the number of eligible patients receiving the performance measure. N2 represents the number of patients eligible for the performance measure.
‡Change of performance measures were tested by the logistic regression model using GEE accounting for within-hospital clustering. §Composite measure by the linear regression model using GEE accounting for within-hospital clustering. nationwide. 4 These main interventions of the quality improvement included the establishment of the National Center of Quality Improvement in Stroke Care, the national guidelines for acute treatment and secondary prevention of stroke, organizational stakeholder and opinion leader meetings, hospital recruitment, collaborative workshops for hospital teams, and hospital tool kits. [4] [5] [6] [7] [8] These improvement tools were previously shown to be successful in continuously improving the quality of care in the GWTG-Stroke. 12, 13 The sensitivity analysis of the 72 hospitals participating in both of 2 phases implied that the sustained participation in the quality improvement initiatives was associated with the better gains. Additionally, the health insurance coverage was improved over time, which could be an important factor for the significant improvement of stroke care quality.
Despite substantial improvement in stroke care quality over time, gaps in adherence to the guideline-based recommendation and clinical practice still exist, even among the top 3 performance measures of early antithrombotics (84.6% in 2012 CNSR versus 97.04% in 2007 GWTG-Stroke), discharge antithrombotics (90.3% in 2012 CNSR versus 98.88% in 2007 GWTG-Stroke), and lipid-lowering drug for low-density lipoprotein ≥100 mg/dL (66.3% in 2012 CNSR versus 88.29% in 2007 GWTG-Stroke). 13 Furthermore, the adherences to intravenous tPA use (18.3%) and anticoagulation for atrial fibrillation (21.0%) were still lowest in 2012 in China, which were far down from GWTG-Stroke (72.84% and 98.39% separately) in 2007. The potential reasons for the low implementation rate of intravenous tPA included the high cost of the tPA, the low health coverage rate, concern for safety of using intravenous tPA in China. 3 Stroke center certification has been proven to increase the use of thrombolytic therapy. 15 However, it was not developed in China. As for the prescription of warfarin, because of the narrow therapeutic margin and drug or food interactions of warfarin, frequent international normalized ratio testing and dose adjustments are required. In China, insufficiency of a comprehensive community health service makes frequent INR testing difficult. Additionally, physicians are concerned about the safety of using warfarin. 16 New oral anticoagulants are an alternative for warfarin and recommended by guidelines without monitoring INR and increasing the risk of hemorrhage. 17 Increased compliance with acute stroke care and secondary prevention guideline-recommended performance metrics is associated with favorable outcomes. 18 Patients in the CNSR phase 2 had better functional outcome at discharge than those in CNRS phase 1. The median length of stay was reduced by 1 day. Meanwhile, the in-hospital mortality was decreased from 4.1% to 1.1%, which was consistent with the findings of the previous study among ischemic stroke patients in China from 2.48% to 1.47% from 2007 to 2010. 19 Patients in the 2012 to 2013 data set were younger and had lower National Institutes of Health Stroke Scale scores, which may decrease the risk of in-hospital death. 20 Second, these improvements of in-hospital outcomes may reflect the quality improvement of in-hospital stroke care and potentially contribute to decreases in the cost of care. 21 Additionally, several confounding factors related with in-hospital mortality should be considered, such as that some families of patients who have severe strokes may request to die at home based on previous wishes in China, the improvement in public awareness resulting in more patients arrived early and treated early, or even changes in length of stay. If stroke patients continue to comply with the prevention measures after discharge, a substantial decline in stroke recurrence may also be predicted according to clinical guidelines. 4, 6, 21 Additionally, given the enormous number of stroke inpatients each year in China, even superficially modestly increased odds of evidence-based health care will convert into enormously more healthcare opportunities to be implemented. These sustained improvements of the quality of care could translate into enormous cost savings in the long term.
Meanwhile, there exist several limitations in this study. First, some of the participating hospitals in 2012 had no baseline data of the quality of care in 2007. The possibility that hospitals in 2012 were simply better all along existed. To reduce this bias, the comparable basic structure characteristics of hospitals between the 2 phases were considered when we selected the potential participating sites in 2012. Improvements in stroke care quality after adjusting for patient-and hospital-level variables were still observed among those 72 returning hospitals, suggesting that the improvements are substantial. The potential reasons that part of the hospitals involved in CNSR phase 1 did not continue through phase 2 included that these quality improvement initiatives required hospitals to invest enough human, material, and funding resources. Second, observed differences of stroke care quality might also reflect the secular trend besides these stroke quality management initiatives themselves. Because stroke care quality was not consecutively recorded among the participating hospitals from 2007 to 2012, this change with time was not analyzed independently as was the case for the GWTG-Stroke. 13 The causal relationship between these initiatives and the improvement of the quality of care could not be established. To prevent these types of bias, a cluster-randomized trial of a targeted multifaceted intervention to bridge the evidence-based gap in the management of acute ischemic stroke in China is ongoing. 22 Additionally, the healthcare delivery varies widely in China, and hospitals voluntarily participating in the CNSRs and network may be interested in the stroke care quality improvement, so the observed findings may not represent the quality of care nationwide.
As the aging process of China's population structure is accelerating, the burden of stroke becomes increasingly heavy. Although improvement of stroke care quality is observed in this study, significant opportunities exist for further improvement. Continuous quality improvement of stroke care should be developed as a sustained priority in China. Efforts that increase the input of the financial and human resources to the stroke care, implement targeted initiatives for improvement of stroke care across the country, develop certification of stroke center, and strengthen physician and public knowledge may contribute to further improvements of the quality of care in China. Zixiao Li et al. The number of total beds per site Annual stroke discharge
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ONLINE SUPPLEMENT Supplemental Tables
The number of discharged patients diagnosed with stroke a year per hospital UBMIS indicates urban basic medical insurance schemes; NRCMS, new rural cooperative medical schemes; CHD, coronary heart disease; MI, myocardial infarction. Stroke education provided to patient and/or caregiver, including all 5 components: modifiable risk factors, stroke warning sign and symptoms, how to activate Emergency Medical Services, need for follow-up, medications prescribed * Eligible patients are those without any medical contraindications (e.g., treatment intolerance, excessive risk of adverse reaction, patient/family refusal, or terminal illness/comfort care only) documented as reasons for nontreatment for each of the applicable measures. For acute performance measures except for rt-PA measure, excludes patients who died before the end of hospital day two. The acute rt-PA measure excludes patients with missing or erroneous onset, arrival or treatment times, those who began IV t-PA at an outside hospital, or who initiated IV t-PA after 180 minutes from onset. For performance measures at discharge, excludes patients who died during hospitalization. 02 NS *Odds ratio (OR) was adjusted for the patient and hospital baseline characteristics set by fitting logistic regression models using generalized estimating equations accounting for within-hospital correlation. CI indicates confidence interval. OR (95% CI) OR (95% CI) †Adjusted for patient characteristics of age, race, gender, insurance schemes, previous stroke/TIA, diabetes, hypertension, dyslipidemia, CHD/previous MI, atrial fibrillation, ever smoking, and stroke severity, and hospital characteristics of times of participating the registries, geographic region, teaching status, number of hospital beds, and annual stroke discharges. ‡Change of performance measures were tested by the logistic regression model using generalized estimated equations (GEE) accounting for within-hospital clustering. §Composite measure by the linear regression model using GEE accounting for within-hospital clustering. SE indicates standard error; IV, intravenous; DVT, deep vein thrombosis; and LDL, low-density lipoprotein.
